Related references
Note: Only part of the references are listed.Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study
Cristina Nombela et al.
BRAIN (2014)
The neurobiological basis of cognitive impairment in Parkinson's disease
Glenda M. Halliday et al.
MOVEMENT DISORDERS (2014)
Serum uric acid and risk of dementia in Parkinson's disease
Isabel Gonzalez-Aramburu et al.
PARKINSONISM & RELATED DISORDERS (2014)
Cognitive and Motor Function in Long-Duration PARKIN-Associated Parkinson Disease
Roy N. Alcalay et al.
JAMA NEUROLOGY (2014)
APOE, MAPT, and SNCA Genes and Cognitive Performance in Parkinson Disease
Ignacio F. Mata et al.
JAMA NEUROLOGY (2014)
Clinical significance of homocysteine (hcy) on dementia in Parkinson's disease (PD)
In-Uk Song et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2013)
Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort
Sophie E. Winder-Rhodes et al.
BRAIN (2013)
Biomarkers in Parkinson's disease (recent update)
Sushil Sharma et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Gray matter atrophy distinguishes between Parkinson disease motor subtypes
Keren Rosenberg-Katz et al.
NEUROLOGY (2013)
Association of a polymorphism in mitochondrial transcription factor A (TFAM) with Parkinson's disease dementia but not dementia with Lewy bodies
Ariana P. Gatt et al.
NEUROSCIENCE LETTERS (2013)
Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
Tobias Skillback et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease
Tiziana Alberio et al.
IUBMB LIFE (2012)
Genetic influences on cognitive decline in Parkinson's disease
James F. Morley et al.
MOVEMENT DISORDERS (2012)
α-Synuclein Genetic Variants Predict Faster Motor Symptom Progression in Idiopathic Parkinson Disease
Beate Ritz et al.
PLOS ONE (2012)
Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease
Tiziana Alberio et al.
SCIENTIFIC REPORTS (2012)
Plasma Epidermal Growth Factor Levels Predict Cognitive Decline in Parkinson Disease
Alice S. Chen-Plotkin et al.
ANNALS OF NEUROLOGY (2011)
Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression
Min Shi et al.
ANNALS OF NEUROLOGY (2011)
Cerebrospinal Fluid Biomarkers in Progranulin Mutations Carriers
Miryam Carecchio et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
The Role of Osteopontin in Neurodegenerative Diseases
Miryam Carecchio et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
The Pattern of Cortical Atrophy in Patients with Parkinson's Disease According to Cognitive Status
Sook K. Song et al.
MOVEMENT DISORDERS (2011)
GBA-associated PD presents with nonmotor characteristics
K. Brockmann et al.
NEUROLOGY (2011)
Osteopontin is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease and Its Levels Correlate with Cognitive Decline
Cristoforo Comi et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease
A. Siderowf et al.
NEUROLOGY (2010)
BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease
F. R. Guerini et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
A single-nucleotide polymorphism of the osteopontin gene may contribute to a susceptibility to Lewy body disease
Walter Maetzler et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
Lucilla Parnetti et al.
BIOLOGICAL PSYCHIATRY (2008)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Mariese A. Hely et al.
MOVEMENT DISORDERS (2008)
Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease
Mario Ezquerra et al.
NEUROSCIENCE LETTERS (2008)
A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies
S. W. Yong et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model
Walter Maetzler et al.
NEUROBIOLOGY OF DISEASE (2007)
Apolipoprotein e and dementia in Parkinson disease -: A meta-analysis
XM Huang et al.
ARCHIVES OF NEUROLOGY (2006)
Brain-derived neurotrophic factor gene polymorphisms and Alzheimer's disease
S Matsushita et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
Share Paper
